Health News

FDA to Determine Fate of Breast Cancer Drug - Again
In a first ever hearing, the U.S. Food and Drug Administration is considering reversing itself on a ruling to withdraw Avastin as a drug to treat metastatic (spread outside of the primary affected organ) breast cancer.
Healthy Lifestyle Changes Impact Cancer Risks
Women can reduce their risks of developing breast cancer with lifestyle changes. Scientists now know just how much those changes impact overall risks in both individuals and populations at large.
Asian & Pacific Islander Breast Cancer Risks
It's commonly believed that breast cancer predominantly affects white women. Actually, certain ethnic groups have similarly high risks of developing the disease.
Breast Cancer Patients Dying Most from Cardiac Problems
Advances in early detection of breast cancer and new treatments mean that more women are now beating the disease. In fact, their chances of survival have increased dramatically.
Radiation Helps Decrease Breast Cancer Recurrence
Some early-stage breast cancers can and do spread to the lymph nodes. While lymph node involvement is never good, new studies show that radiation helps keep these cancers from returning.
FDA Approves New Breast Cancer Test
The U.S. Food and Drug Administration (FDA) today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin ( trastuzumab ), a commonly used breast cancer treatment.
Blood Test for Breast Cancer Patients
Every breast cancer is as unique as the patient who has it. Understanding how the cancer progresses is key to making effective treatment decisions.
New Facts are in: Fat is Fatal
Obesity continues to be linked to a number of diseases. Now it's shown to be a predictor of who does - and doesn't - survive breast cancer.
Drug Helps Prevent Breast Cancer
A drug currently being used to treat breast cancer has been shown to significantly reduce the risk of developing the disease. The aromatase inhibitor, Aromasin (exemestane), helps post-menopausal women avoid breast cancer altogether.
Still Cinderella With HRT
Women with a form of genetic breast cancer risk are often urged to have their ovaries removed after childbearing to prevent cancer occurence. This unfortunately causes early menopause, and it was believed that taking hormone replacement therapy to alleviate symptoms was dangerous.